Literature DB >> 17928527

Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells.

Yoshinori Yamanishi1, Jiro Kitaura, Kumi Izawa, Takayuki Matsuoka, Toshihiko Oki, Yang Lu, Fumi Shibata, Satoshi Yamazaki, Hidetoshi Kumagai, Hideaki Nakajima, Mari Maeda-Yamamoto, Victor L J Tybulewicz, Toshiyuki Takai, Toshio Kitamura.   

Abstract

We have analyzed leukocyte mono-Ig-like receptor 5 (LMIR5) as an activating receptor among paired LMIRs. Mouse LMIR5 (mLMIR5) is expressed in myeloid cells such as mast cells, granulocytes, macrophages, and dendritic cells. Cross-linking of transduced mLMIR5 in bone marrow-derived mast cells (BMMCs) caused activation events, including cytokine production, cell survival, degranulation, and adhesion to the extracellular matrix. mLMIR5 associated with DAP12 and to a lesser extent with DAP10, and mLMIR5-mediated functions of BMMCs were strongly inhibited by DAP12 deficiency. Importantly, cross-linking of endogenous mLMIR5 induced Syk-dependent activation of fetal liver-derived mast cells. Unlike mLMIR5, cross-linking of human LMIR5 (hLMIR5) induced cytokine production of BMMCs even in the absence of both DAP12 and DAP10, suggesting the existence of unidentified adaptors. Interestingly, hLMIR5 possessed a tyrosine residue (Y188) in the cytoplasmic region. Signaling via Y188 phosphorylation played a predominant role in hLMIR5-mediated cytokine production in DAP12-deficient, but not wild-type BMMCs. In addition, experiments using DAP10/DAP12 double-deficient BMMCs suggested the existence of Y188 phoshorylation-dependent and -independent signals from unidentified adaptors. Collectively, although both mouse and human LMIR5 play activatory roles in innate immunity cells, the functions of LMIR5 were differentially regulated in mouse versus human cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928527     DOI: 10.1182/blood-2007-04-085787

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation.

Authors:  Agueda Martínez-Barriocanal; Emma Comas-Casellas; Simo Schwartz; Margarita Martín; Joan Sayós
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 2.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

3.  Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.

Authors:  Xiaoming Shi; Mingjian Zhang; Fang Liu; Zhengxing Wang; Luding Zhang; Haifei Cheng; Shu Zhang; Teng Fei; Meng Guo; Jun Bian; Quanxing Wang; Guoshan Ding
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

4.  Plastic changes along auditory pathway during salicylate-induced ototoxicity: Hyperactivity and CF shifts.

Authors:  Chen Jiang; Bin Luo; Senthilvelan Manohar; Guang-Di Chen; Richard Salvi
Journal:  Hear Res       Date:  2016-10-27       Impact factor: 3.208

5.  Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5.

Authors:  Yutaka Enomoto; Yoshinori Yamanishi; Kumi Izawa; Ayako Kaitani; Mariko Takahashi; Akie Maehara; Toshihiko Oki; Reiko Takamatsu; Masunori Kajikawa; Toshiyuki Takai; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

6.  Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.

Authors:  Yuki Kagiyama; Jiro Kitaura; Katsuhiro Togami; Tomoyuki Uchida; Daichi Inoue; Toshihiro Matsukawa; Kumi Izawa; Kimihito C Kawabata; Yukiko Komeno; Toshihiko Oki; Fumio Nakahara; Katsuaki Sato; Hiroyuki Aburatani; Toshio Kitamura
Journal:  Int J Hematol       Date:  2012-10-25       Impact factor: 2.490

7.  TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

Authors:  Yoshinori Yamanishi; Jiro Kitaura; Kumi Izawa; Ayako Kaitani; Yukiko Komeno; Masaki Nakamura; Satoshi Yamazaki; Yutaka Enomoto; Toshihiko Oki; Hisaya Akiba; Takaya Abe; Tadasuke Komori; Yoshihiro Morikawa; Hiroshi Kiyonari; Toshiyuki Takai; Ko Okumura; Toshio Kitamura
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

8.  Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Authors:  Mariko Takahashi; Kumi Izawa; Jun-ichi Kashiwakura; Yoshinori Yamanishi; Yutaka Enomoto; Ayako Kaitani; Akie Maehara; Masamichi Isobe; Shinichi Ito; Toshihiro Matsukawa; Fumio Nakahara; Toshihiko Oki; Masunori Kajikawa; Chisei Ra; Yoshimichi Okayama; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

9.  Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family.

Authors:  Kouta Niizuma; Satoko Tahara-Hanaoka; Emiko Noguchi; Akira Shibuya
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

10.  Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.

Authors:  Mark T Orr; Joseph C Sun; David G T Hesslein; Hisashi Arase; Joseph H Phillips; Toshiyuki Takai; Lewis L Lanier
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.